Algenetix Raises $2M for Proprietary PhotoSeedTM Single Cell Oil Technology

SAN DIEGO--()--Algenetix, an industrial biotech company incubated from the pipeline of Kapyon Ventures, LLC, is pleased to announce it has closed $2.0M in Series A-1 funding to further commercialize its PhotoSeed platform. The groundbreaking technology vastly improves oil productivity in microbes by accelerating oil accumulation and subsequently preventing its degradation in the cell. The company’s funding is led by Two Oceans and local San Diego investors, and supported by Algenetix’s Executive Chairman, Dr. Jerry Caulder. With this funding, Algenetix will further advance its PhotoSeed program and develop renewable oils that can sustainably replace petroleum for fuels and chemicals without compromising land and food production resources.

“We have created a compelling IP portfolio and, with the support of Two Oceans and our existing investors, we are able to develop the technology more broadly than previously possible,” says Han Chen, CEO of Algenetix. “In addition to the capital, the investment has also expanded our visibility and engagement with new partnerships in North America, Australia, the Middle East and South East Asia - all of which are important markets.”

“Algenetix is an exciting new player making valuable feed stocks for chemicals, food and materials utilizing single cell organisms, such as yeast and algae,” says Arama Kukutai, Managing Director, Finistere Ventures GP II. “Unlike other similar technologies, Algenetix is charting a path to economically produce feed stocks that use low cost inputs and existing fermentation capacity under a very capital efficient business model, which is fitting for the current funding climate.”

Algenetix will be conducting the development in partnership with the laboratories of Dr. Janet Donaldson at Mississippi State University.

Algenetix (www.algenetix.com):

Algenetix is an industrial biotech company incubated from the Kapyon Ventures pipeline. The company develops single cell petrochemical alternatives using its proprietary PhotoSeed technology, which improves lipid productivity in industrial microbes.

Two Oceans:

Two Oceans is a Family Office based in Sydney, Australia, and is a potential limited partner in Finistere Venture’s Fund II.

Kapyon Ventures (www.kapyon.com):

Kapyon Ventures is a San Diego based incubation firm focused on the development of technology startups from global research institutes. Kapyon's areas of focus include agricultural biotechnology, industrial biotechnology and cleantech. It works closely with U.S. and international research partners as managers for an investment portfolio of several biotechnology joint ventures.

Contacts

For Algenetix
Lauren Lehman
858-437-1107
llehman@l3healthcare.com

Sharing

Contacts

For Algenetix
Lauren Lehman
858-437-1107
llehman@l3healthcare.com